Matches in Wikidata for { <http://www.wikidata.org/entity/Q91967808> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q91967808 description "article scientifique publié en 2019" @default.
- Q91967808 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91967808 description "scientific article published on 13 December 2019" @default.
- Q91967808 description "wetenschappelijk artikel" @default.
- Q91967808 description "наукова стаття, опублікована 13 грудня 2019" @default.
- Q91967808 name "Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
- Q91967808 name "Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
- Q91967808 type Item @default.
- Q91967808 label "Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
- Q91967808 label "Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
- Q91967808 prefLabel "Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
- Q91967808 prefLabel "Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
- Q91967808 P1433 Q91967808-937E7B12-20A3-43BC-825F-1F8A86B07109 @default.
- Q91967808 P1476 Q91967808-3E52EEA6-C562-415D-A3CB-707AF5CC44FD @default.
- Q91967808 P2093 Q91967808-0469F1E8-B7C7-4D97-9C4D-341026040067 @default.
- Q91967808 P2093 Q91967808-0701EFEE-BD56-4215-AEB8-11F2015DFC70 @default.
- Q91967808 P2093 Q91967808-1112AA57-CF4D-4344-B173-6982F2F659EA @default.
- Q91967808 P2093 Q91967808-5788F110-0EC5-4FF7-9C5B-313457B64055 @default.
- Q91967808 P2093 Q91967808-588DD21C-7408-466D-B1C3-720509DABE2D @default.
- Q91967808 P2093 Q91967808-603CFFF8-E783-4A7B-8B3D-913DA44A7873 @default.
- Q91967808 P2093 Q91967808-70F366AB-2896-4EE1-AC50-E6412AE9CDF4 @default.
- Q91967808 P2093 Q91967808-886A2C6D-41E2-4D55-BF75-1EB1692BF6C9 @default.
- Q91967808 P2093 Q91967808-95256200-2C7E-43BE-A35A-9A553C2FF442 @default.
- Q91967808 P2093 Q91967808-A32D8BFD-AB40-42DF-AE62-423DFF4A0620 @default.
- Q91967808 P2093 Q91967808-D4372464-3545-49EC-B77D-19B80EC481E6 @default.
- Q91967808 P2093 Q91967808-F3A06397-1E14-4045-A367-369BA358AD52 @default.
- Q91967808 P2093 Q91967808-F798843F-870C-41C6-A24C-F039A7F549BF @default.
- Q91967808 P2860 Q91967808-10790C76-4F20-4BEA-9169-EE6E08DE70CA @default.
- Q91967808 P304 Q91967808-43832195-C238-4F24-A9BF-B7C2B106B459 @default.
- Q91967808 P31 Q91967808-C87B9441-9F31-4AD7-9587-E5E2829D591D @default.
- Q91967808 P31 Q91967808-DE827734-C8D1-47F9-AF1D-DE2906E41076 @default.
- Q91967808 P356 Q91967808-86C668DC-B877-4EB3-BA35-FD0D4D2FA2BA @default.
- Q91967808 P433 Q91967808-D40775CD-40D8-4E01-AF7B-DDEF2F403DA8 @default.
- Q91967808 P478 Q91967808-248A585E-7550-4FBB-B704-8819951248CB @default.
- Q91967808 P50 Q91967808-58CA4A14-1B20-4728-AD1D-08AC229321E7 @default.
- Q91967808 P50 Q91967808-ED6CFE29-F245-4AF7-B98E-37E9F1441B04 @default.
- Q91967808 P577 Q91967808-AFA35CDD-D910-429D-9683-BE77208F714D @default.
- Q91967808 P698 Q91967808-4B26A56E-ADEA-47F7-8558-F21B7F3E9129 @default.
- Q91967808 P921 Q91967808-37BC5BA2-591E-47E8-8616-E7340405FE24 @default.
- Q91967808 P932 Q91967808-75CDD5D3-07F0-4485-BEC6-58084A51585D @default.
- Q91967808 P356 S13063-019-3940-0 @default.
- Q91967808 P698 31836017 @default.
- Q91967808 P1433 Q7840023 @default.
- Q91967808 P1476 "Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
- Q91967808 P2093 "Beatriz Mothe" @default.
- Q91967808 P2093 "Eric Florence" @default.
- Q91967808 P2093 "Félipe Garcia" @default.
- Q91967808 P2093 "Guido Vanham" @default.
- Q91967808 P2093 "Joeri Aerts" @default.
- Q91967808 P2093 "Jozefien Buyze" @default.
- Q91967808 P2093 "Kris Thielemans" @default.
- Q91967808 P2093 "Lorna Leal" @default.
- Q91967808 P2093 "Montse Plana" @default.
- Q91967808 P2093 "Rob Gruters" @default.
- Q91967808 P2093 "Sabine Allard" @default.
- Q91967808 P2093 "Wesley de Jong" @default.
- Q91967808 P2093 "iHIVARNA consortium" @default.
- Q91967808 P2860 Q92820217 @default.
- Q91967808 P304 "721" @default.
- Q91967808 P31 Q13442814 @default.
- Q91967808 P31 Q1348305 @default.
- Q91967808 P356 "10.1186/S13063-019-3940-0" @default.
- Q91967808 P433 "1" @default.
- Q91967808 P478 "20" @default.
- Q91967808 P50 Q42392436 @default.
- Q91967808 P50 Q88002275 @default.
- Q91967808 P577 "2019-12-13T00:00:00Z" @default.
- Q91967808 P698 "31836017" @default.
- Q91967808 P921 Q269829 @default.
- Q91967808 P932 "6909442" @default.